BIODYNAMIC FORECASTING

What this means for you

This application is over — abandoned 31 Oct 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98201723

Mark type

Stylized text

Filed

28 Sept 2023

Abandoned

31 Oct 2024

Attorney of record

Christina Licursi

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable computer software using artificial intelligence, computational methods, and machine learning models for data analysis in the fields of healthcare, wellness, nervous system dysregulation, disease, biomedical, and genomic research; Downloadable computer software using artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in the field of drug discovery and development; Downloadable computer software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information, and artificial intelligence in the fields of healthcare, biomedical, and genomic research; Downloadable computer software using artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks
• Class 042 — Scientific and technological services: Providing on-line non-downloadable software using artificial intelligence, computational methods, and machine learning models for data analysis in the fields of healthcare, wellness, nervous system dysregulation, disease, biomedical, and genomic research; Providing on-line non-downloadable software using artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in the field of drug discovery and development; Providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information, and artificial intelligence in the fields of healthcare, biomedical, and genomic research; scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and research relating to healthcare, wellness, system dysregulation, disease, and genomics; Providing on-line non-downloadable software using artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products

Owner

• ETIOME, INC., CAMBRIDGE, MA, US
• Flagship Labs 84, Inc., Cambridge, MA, US

Prosecution history

• 15 Nov 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
• 15 Nov 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
• 26 Jul 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 25 Jun 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 25 Jun 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 30 Apr 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 30 Apr 2024 — FINAL REFUSAL E-MAILED
• 30 Apr 2024 — FINAL REFUSAL WRITTEN
• 10 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 10 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 10 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 31 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 31 Jan 2024 — NON-FINAL ACTION E-MAILED
• 31 Jan 2024 — NON-FINAL ACTION WRITTEN
• 24 Jan 2024 — ASSIGNED TO EXAMINER